Table 4.
Direction of biomarker change from baseline to end of treatment | n | Patients with an event, n | Event proportion, % | Odds ratio | 95% CI | P‐value |
---|---|---|---|---|---|---|
hsCRP | ||||||
Increase | 142 | 31 | 21.8% | 0.58 | 0.31–1.08 | 0.08 |
Decrease | 186 | 26 | 14.0% | |||
SUA | ||||||
Increase | 176 | 35 | 19.9% | 0.70 | 0.38–1.27 | 0.26 |
Decrease | 169 | 25 | 14.8% |
CI, confidence interval; hsCRP, high‐sensitivity C‐reactive protein; SUA, serum uric acid.